AMN Healthcare Services (AMN) Price Target Cut by JMP Securities to $22.00
PorAinvest
martes, 12 de agosto de 2025, 7:29 pm ET1 min de lectura
AMN--
Analysts have responded to these results with varied opinions. JMP Securities' Constantine Davides maintained a "Market Outperform" rating but reduced the price target from $33 to $22, a 33.33% decrease [3]. This adjustment was echoed by BMO Capital, which also lowered its price target from $27 to $22, citing a more cautious outlook on AMN's potential growth [2]. The average target price from seven analysts is $22, with estimates ranging from $18 to $33, indicating a potential 33.41% upside from the current price of $16.49 [3].
Despite the downward revision in price targets, AMN's stock has shown resilience. The company's shares are currently trading at $16.87, down from $16.73 a week ago, but up from a low of $14.87 over the past year [2]. The estimated GF Value in one year is $50.52, suggesting a potential 206.37% upside [3].
AMN Healthcare Services continues to operate as a leading player in the healthcare staffing industry, offering a range of workforce solutions and staffing services to healthcare facilities across the United States. The company's ability to meet and exceed financial targets in certain areas, such as its allied staffing business, highlights its potential for future growth.
References:
[1] https://finance.yahoo.com/news/amn-healthcare-services-second-quarter-133140781.html
[2] https://site.financialmodelingprep.com/market-news/amn-healthcare-services-strong-q2-2025-financials-industry-leadership
[3] https://www.gurufocus.com/news/3048076/q2-2025-amn-healthcare-services-inc-earnings-call-transcript
Analyst Constantine Davides from JMP Securities has maintained a "Market Outperform" rating for AMN Healthcare Services (AMN) but lowered the price target from $33 to $22, a 33.33% decrease. The average target price from 7 analysts is $22, with a high estimate of $33 and a low of $18, implying a 33.41% upside from the current price of $16.49. The estimated GF Value in one year is $50.52, suggesting a 206.37% upside.
AMN Healthcare Services (NYSE: AMN) reported its second-quarter 2025 results, revealing mixed financial performance. The company posted revenue of $658.2 million, a 11% decline from the same period last year [1]. Despite the revenue decrease, the net loss was $116.2 million, down from a profit of $16.2 million in the previous quarter, with earnings per share (EPS) falling to $3.03 from $0.42 [1].Analysts have responded to these results with varied opinions. JMP Securities' Constantine Davides maintained a "Market Outperform" rating but reduced the price target from $33 to $22, a 33.33% decrease [3]. This adjustment was echoed by BMO Capital, which also lowered its price target from $27 to $22, citing a more cautious outlook on AMN's potential growth [2]. The average target price from seven analysts is $22, with estimates ranging from $18 to $33, indicating a potential 33.41% upside from the current price of $16.49 [3].
Despite the downward revision in price targets, AMN's stock has shown resilience. The company's shares are currently trading at $16.87, down from $16.73 a week ago, but up from a low of $14.87 over the past year [2]. The estimated GF Value in one year is $50.52, suggesting a potential 206.37% upside [3].
AMN Healthcare Services continues to operate as a leading player in the healthcare staffing industry, offering a range of workforce solutions and staffing services to healthcare facilities across the United States. The company's ability to meet and exceed financial targets in certain areas, such as its allied staffing business, highlights its potential for future growth.
References:
[1] https://finance.yahoo.com/news/amn-healthcare-services-second-quarter-133140781.html
[2] https://site.financialmodelingprep.com/market-news/amn-healthcare-services-strong-q2-2025-financials-industry-leadership
[3] https://www.gurufocus.com/news/3048076/q2-2025-amn-healthcare-services-inc-earnings-call-transcript
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios